Cargando…

Recognition of allergic conjunctivitis in patients with allergic rhinitis

AIMS: To identify the incidence of allergic conjunctivitis in patients with allergic rhinitis. METHODS: One hundred and eighty seven consecutive patients with allergic rhinitis (AR) were directly questioned if they have allergic conjunctivitis (AC) and this was clarified using standard screening que...

Descripción completa

Detalles Bibliográficos
Autores principales: Williams, Daniel C, Edney, Gabrielle, Maiden, Bianca, Smith, Peter K
Formato: Online Artículo Texto
Lenguaje:English
Publicado: World Allergy Organization 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3646537/
https://www.ncbi.nlm.nih.gov/pubmed/23663473
http://dx.doi.org/10.1186/1939-4551-6-4
_version_ 1782268609039433728
author Williams, Daniel C
Edney, Gabrielle
Maiden, Bianca
Smith, Peter K
author_facet Williams, Daniel C
Edney, Gabrielle
Maiden, Bianca
Smith, Peter K
author_sort Williams, Daniel C
collection PubMed
description AIMS: To identify the incidence of allergic conjunctivitis in patients with allergic rhinitis. METHODS: One hundred and eighty seven consecutive patients with allergic rhinitis (AR) were directly questioned if they have allergic conjunctivitis (AC) and this was clarified using standard screening questions relating to red, itchy and watery eyes recorded through a total ocular symptom score (TOSS). Patients were also asked about further symptoms that may be attributable to AC: eyelid dermatitis, frequent blinking; eye sensitivity and frontal headache from squinting or. blinking. All patients were given a drop of olopatadine hydrochloride 0.1% in each eye to help identify “silent” disease. 20 healthy non-atopic controls were also treated with olopatadine drops and questioned on ocular symptoms. RESULTS: Fifty five percent of patients with AR were identified as having AC by direct questioning and the use of the TOSS questionaire. A further 41% were identifiable by asking additional questions and performing therapeutic challenge with olopadatine. CONCLUSIONS: AC is a frequent comorbid condition occurring in 95% of our patients with AR. Only 55% of patients were able to identify that they had AC based on standard screening questions. Additional specific questioning and a therapeutic challenge in suspected patients can help identify patients who may benefit from treatment of AC.
format Online
Article
Text
id pubmed-3646537
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher World Allergy Organization
record_format MEDLINE/PubMed
spelling pubmed-36465372013-05-08 Recognition of allergic conjunctivitis in patients with allergic rhinitis Williams, Daniel C Edney, Gabrielle Maiden, Bianca Smith, Peter K World Allergy Organ J Original Research AIMS: To identify the incidence of allergic conjunctivitis in patients with allergic rhinitis. METHODS: One hundred and eighty seven consecutive patients with allergic rhinitis (AR) were directly questioned if they have allergic conjunctivitis (AC) and this was clarified using standard screening questions relating to red, itchy and watery eyes recorded through a total ocular symptom score (TOSS). Patients were also asked about further symptoms that may be attributable to AC: eyelid dermatitis, frequent blinking; eye sensitivity and frontal headache from squinting or. blinking. All patients were given a drop of olopatadine hydrochloride 0.1% in each eye to help identify “silent” disease. 20 healthy non-atopic controls were also treated with olopatadine drops and questioned on ocular symptoms. RESULTS: Fifty five percent of patients with AR were identified as having AC by direct questioning and the use of the TOSS questionaire. A further 41% were identifiable by asking additional questions and performing therapeutic challenge with olopadatine. CONCLUSIONS: AC is a frequent comorbid condition occurring in 95% of our patients with AR. Only 55% of patients were able to identify that they had AC based on standard screening questions. Additional specific questioning and a therapeutic challenge in suspected patients can help identify patients who may benefit from treatment of AC. World Allergy Organization 2013-02-12 /pmc/articles/PMC3646537/ /pubmed/23663473 http://dx.doi.org/10.1186/1939-4551-6-4 Text en Copyright ©2013 Williams et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Research
Williams, Daniel C
Edney, Gabrielle
Maiden, Bianca
Smith, Peter K
Recognition of allergic conjunctivitis in patients with allergic rhinitis
title Recognition of allergic conjunctivitis in patients with allergic rhinitis
title_full Recognition of allergic conjunctivitis in patients with allergic rhinitis
title_fullStr Recognition of allergic conjunctivitis in patients with allergic rhinitis
title_full_unstemmed Recognition of allergic conjunctivitis in patients with allergic rhinitis
title_short Recognition of allergic conjunctivitis in patients with allergic rhinitis
title_sort recognition of allergic conjunctivitis in patients with allergic rhinitis
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3646537/
https://www.ncbi.nlm.nih.gov/pubmed/23663473
http://dx.doi.org/10.1186/1939-4551-6-4
work_keys_str_mv AT williamsdanielc recognitionofallergicconjunctivitisinpatientswithallergicrhinitis
AT edneygabrielle recognitionofallergicconjunctivitisinpatientswithallergicrhinitis
AT maidenbianca recognitionofallergicconjunctivitisinpatientswithallergicrhinitis
AT smithpeterk recognitionofallergicconjunctivitisinpatientswithallergicrhinitis